Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.24 Million AUD | -9.0% |
| 2022 | 3.56 Million AUD | 11440.36% |
| 2021 | 30.87 Thousand AUD | -89.8% |
| 2020 | 302.74 Thousand AUD | -50.77% |
| 2019 | 615.01 Thousand AUD | 3236.33% |
| 2018 | 18.43 Thousand AUD | -62.63% |
| 2017 | 49.32 Thousand AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 3.43 Million AUD | 12.36% |
| 2014 | 3.05 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 3.24 Million AUD | -9.0% |
| 2023 Q3 | 3.24 Million AUD | 4.25% |
| 2023 Q4 | 3.24 Million AUD | 0.0% |
| 2023 Q1 | 3.11 Million AUD | -12.7% |
| 2023 Q2 | 3.11 Million AUD | 0.0% |
| 2022 Q2 | 3.99 Million AUD | 0.0% |
| 2022 Q4 | 3.56 Million AUD | 0.0% |
| 2022 FY | 3.56 Million AUD | 11440.36% |
| 2022 Q1 | 3.99 Million AUD | 12825.21% |
| 2022 Q3 | 3.56 Million AUD | -10.71% |
| 2021 Q1 | 37.91 Thousand AUD | -87.48% |
| 2021 FY | 30.87 Thousand AUD | -89.8% |
| 2021 Q4 | 30.87 Thousand AUD | 0.0% |
| 2021 Q3 | 30.87 Thousand AUD | -18.57% |
| 2021 Q2 | 37.91 Thousand AUD | 0.0% |
| 2020 FY | 302.74 Thousand AUD | -50.77% |
| 2020 Q1 | 451.48 Thousand AUD | -26.59% |
| 2020 Q2 | 451.48 Thousand AUD | 0.0% |
| 2020 Q4 | 302.74 Thousand AUD | 0.0% |
| 2020 Q3 | 302.74 Thousand AUD | -32.94% |
| 2019 Q1 | 18.55 Thousand AUD | 0.64% |
| 2019 Q3 | 615.01 Thousand AUD | 3215.11% |
| 2019 Q4 | 615.01 Thousand AUD | 0.0% |
| 2019 FY | 615.01 Thousand AUD | 3236.33% |
| 2019 Q2 | 18.55 Thousand AUD | 0.0% |
| 2018 Q4 | 18.43 Thousand AUD | 0.0% |
| 2018 Q2 | 52.05 Thousand AUD | 0.0% |
| 2018 Q1 | 52.05 Thousand AUD | 5.53% |
| 2018 FY | 18.43 Thousand AUD | -62.63% |
| 2018 Q3 | 18.43 Thousand AUD | -64.59% |
| 2017 Q2 | 66.63 Thousand AUD | 0.0% |
| 2017 Q1 | 66.63 Thousand AUD | 0.0% |
| 2017 FY | 49.32 Thousand AUD | 0.0% |
| 2017 Q4 | 49.32 Thousand AUD | 0.0% |
| 2017 Q3 | 49.32 Thousand AUD | -25.97% |
| 2016 FY | - AUD | -100.0% |
| 2015 FY | 3.43 Million AUD | 12.36% |
| 2014 FY | 3.05 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -53945.0% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -149.916% |
| Biocept, Inc. | 10.37 Million USD | 68.745% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 93.68% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 94.704% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -493.549% |
| iMD Companies, Inc. | 1.1 Million USD | -193.812% |
| IDenta Corp. | 428.17 Thousand USD | -657.329% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 23.575% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -1066.439% |
| NovelStem International Corp. | 3.32 Million USD | 2.463% |
| Optigenex Inc. | 4.42 Million USD | 26.753% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -98.817% |
| Response Genetics, Inc | 4.91 Million USD | 34.065% |
| Rennova Health, Inc. | 359.19 Thousand USD | -802.774% |
| RushNet, Inc. | 4.25 Million USD | 23.744% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -1202.028% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -306.129% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -462.596% |
| Todos Medical Ltd. | 33 Million USD | 90.174% |